Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT00470977
Previous Study | Return to List | Next Study

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (FVF4140S)

This study has been completed.
Genentech, Inc.
Information provided by (Responsible Party):
Joan, Manhattan Eye, Ear & Throat Hospital Identifier:
First received: May 4, 2007
Last updated: October 24, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)